Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycobacterium xenopi, a potential human pathogen.

A Lavy1, R Rusu, A Mates

  • 1Mycobacterium Reference Laboratory, A. Felix Public Health Laboratories, Tel Aviv, Israel.

Israel Journal of Medical Sciences
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary hypertension in patients with end stage renal disease undergoing hemodialysis.

Nigerian journal of clinical practice·2020
Same author

Microbiological Survey of Frozen Ground Meat and a Proposed Standard.

Journal of food protection·2019
Same author

ICMSF Methods Studies. XIV. Comparative Study on Recovery of Salmonella from Refrigerated Preenrichment and Enrichment Broth Cultures.

Journal of food protection·2019
Same author

Corrigendum: methotrexate in chronic active Crohn's disease: a double-blind, randomized, israeli multicenter trial.

The American journal of gastroenterology·2015
Same author

Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial.

Clinical and experimental immunology·2015
Same author

[Hyperhomocysteinemia, risk factor in deep venous thrombosis: a case-control study].

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi·2011

Mycobacterium xenopi rarely causes lung disease. This study identified M. xenopi in patients and hospital hot water, suggesting environmental contamination as a source of pulmonary mycobacteriosis.

Area of Science:

  • Microbiology
  • Pulmonary Medicine
  • Environmental Health

Background:

  • Mycobacterium xenopi is an atypical mycobacterium infrequently associated with human disease.
  • Pulmonary infections caused by mycobacteria require accurate diagnosis and appropriate treatment strategies.

Observation:

  • A 12-year survey (1978-1989) identified 108 strains of Mycobacterium xenopi from 90 individuals and 6 hot water samples.
  • Most isolates were from patients at Barzilai Hospital, Ashkelon, prompting an investigation into local environmental sources.

Findings:

  • Three patients were diagnosed with pulmonary mycobacteriosis caused by Mycobacterium xenopi.
  • Treatment outcomes for these cases were variable, influenced by patient condition and drug sensitivity.
  • Environmental sampling confirmed Mycobacterium xenopi presence in the hospital's hot water system, indicating a likely source of contamination.

Related Experiment Videos

Implications:

  • This study highlights the potential for Mycobacterium xenopi to cause pulmonary disease.
  • Identifying environmental reservoirs, such as hot water systems, is crucial for preventing and managing mycobacterial infections.
  • Further research into M. xenopi's pathogenicity and transmission routes is warranted.